WHOLE
CELL
HEATKILLED
GRAMNEGATIVE
BACILLI
VACCINE
THIS
PRELIMINARY
CLINICAL
STUDY
IS
OF
THE
ABILITY
OF
A
MULTIVALENT
HEATKILLED
WHOLE
CELL
GRAMNEGATIVE
BACILLI
VACCINE
TO
BE
TOLERATED
AND
TO
EVOKE
AN
ANTIBODY
RESPONSE
IN
GROUPS
OF
PATIENTS
WHO
HAVE
A
MANIFEST
NEED
FOR
INCREASED
RESISTANCE
TO
GRAMNEGATIVE
BACILLI
THREE
GROUPS
OF
PATIENTS
WERE
STUDIED
35
BURN
PATIENTS
SEVEN
SMALL
CHILDREN
WITH
CYSTIC
FIBROSIS
AND
35
PATIENTS
WHO
WERE
ABOUT
TO
UNDERGO
CORONARY
VEIN
GRAFTS
THE
RESULTS
OF
VACCINATION
WERE
DIFFERENT
IN
EACH
OF
THE
THREE
GROUPS
OF
PATIENTS
THAT
WERE
VACCINATED
